In focus
Latest feed
BridgeBio's Attruby Appears to Outshine Pfizer's Vyndamax in Crucial Real-World Study for ATTR-CM
UCLA Scientists Engineer 'Triple-Threat' Immune Cells, Offering New Hope Against Heart Attacks and Strokes
A Beacon of Hope: Cytokinetics' Myqorzo Delivers Promising Results for Overlooked Heart Condition
From Illinois Labs to Life-Saving Breakthroughs: The Story of a Pancreatic Cancer Drug
